';

The origin of precision medicine.

Cutting-edge technologies and analytics that enable precision medicine.

Improve global health through early detection,
diagnosis and management of diseases.

Artemis DNA™ Cancer Risk Profile Panel

Next-generation sequencing (NGS) assay that assesses a person’s increased risk of developing the disease based on their genetic makeup.

Artemis DNA™ Trucheck Pragma Cancer Early Detection Panel

Liquid biopsy test that is intended for early detection of Lung, Stomach, Colon, Pancreas, Prostate, Breast and Ovarian cancers.

Artemis DNA™ Cancertrack Cancer Monitor and Manage Recurrence Panel

Liquid biopsy test that analyses ctDNA, CTCs and/or exosomes in the course of cancer. Recurrences or disease progression can thus be detected as early as possible and therapy can be adjusted.

Artemis DNA™ Cancer Tumor Profiling Panel

Next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling of tumor samples.